Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

ABVC

ABVC BIOPHARMA, INC.

Healthcare · Pharmaceuticals

$1.05Sep 28, 2026

AI confidence 71% · refreshes every 15s during session

Investment Snapshot

Weak evidence · 1 source

Why it matters

ABVC BIOPHARMA, INC. shows accelerating business momentum based on AlphaOS pipeline evidence.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Pipeline evidence · 22d ago

ABVC's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on ABVC.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q3 2025

Full ABVC earnings analysis

Reported figures for ABVC BIOPHARMA, INC. — research only, not investment advice.

Revenue YoY
+104.5%

Latest Intelligence

Updated

What happened recently for ABVC BIOPHARMA, INC. (ABVC) — events, not interpretation.

Event
Reported Q3 2025 revenue +105% YoY.
Also
Last session September 28, 2026 at $1.05.
Source
Q3 2025 earnings

Research & analysis only — not investment advice.

Building company intelligence…

ABVC BIOPHARMA, INC. (ABVC)

Healthcare · Pharmaceuticals

Investment Snapshot above is the primary AlphaOS analysis for ABVC BIOPHARMA, INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$27.99M
Revenue:
$795,950

ABVC earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow ABVC BIOPHARMA, INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.